Gut microbiota dysbiosis further exacerbates CRS by producing uremic toxins (e.g., TMAO), which enhance inflammation and fibrosis via NF-κB and TGF-β1 pathways (31, 32). The gene discussed is NFKB1; the disease is congenital rubella syndrome.